Zhongchao Inc SEC Filings

ZCMD NASDAQ

Welcome to our dedicated page for Zhongchao SEC filings (Ticker: ZCMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Medical-education revenue, patient-support programs, and a Cayman Islands holding structure make Zhongchao Inc’s disclosures anything but routine. Investors hunting for segment growth or VIE-related risks often type “Zhongchao Inc SEC filings explained simply,” yet still meet pages of technical language. This page delivers what they are after—understanding Zhongchao Inc SEC documents with AI that converts dense text into concise, plain-English insights.

As soon as a document hits EDGAR, Stock Titan supplies AI-powered summaries, cross-linked exhibits, and red-flag alerts. Use it to track Zhongchao Inc insider trading Form 4 transactions, receive Zhongchao Inc Form 4 insider transactions real-time notifications, and open the Zhongchao Inc quarterly earnings report 10-Q filing without wading through footnotes. Need depth? Our dashboard pairs the Zhongchao Inc annual report 10-K simplified review with side-by-side ratios so you can complete Zhongchao Inc earnings report filing analysis in minutes.

Form 10-K annual report
Form 10-Q quarterly update
Form 8-K material events
Form 4 insider transactions
DEF 14A proxy for compensation

China’s healthcare rules change quickly, so the next Zhongchao Inc 8-K material events explained section matters. The same workspace houses the Zhongchao Inc proxy statement executive compensation details and flags Zhongchao Inc executive stock transactions Form 4 to show how management responds to policy shifts. Whether you monitor patient-management revenue lines, provider-enrollment numbers, or medication-assistance costs, our real-time coverage and AI commentary transform every filing into practical intelligence.

06/25/2025 12:15 AM

Filing

[EFFECT] Zhongchao Inc. SEC Filing

Rhea-AI Summary

The SEC has declared Zhongchao's Form F-3 registration statement effective as of June 24, 2025 at 4:00 P.M. The registration statement was filed under file number 333-279667.

Form F-3 is a simplified securities registration form used by foreign private issuers that have met certain reporting requirements. This effectiveness notice indicates that Zhongchao has received regulatory approval to proceed with their securities offering as outlined in the registration statement.

This development is significant for investors as it enables Zhongchao to:

Access U.S. capital markets through shelf registration
Issue various types of securities over time without additional registration requirements
Respond quickly to market opportunities for raising capital

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Zhongchao (ZCMD)?

The current stock price of Zhongchao (ZCMD) is $1.14 as of June 28, 2025.

What is the market cap of Zhongchao (ZCMD)?

The market cap of Zhongchao (ZCMD) is approximately 31.6M.

What does Zhongchao Inc specialize in?

Zhongchao Inc specializes in providing comprehensive healthcare information, education, and training services through digital platforms that serve healthcare professionals and the public in China.

How does Zhongchao Inc support healthcare professionals?

The company offers a range of online and onsite educational programs, including interactive case studies, academic conferences, and continuing education courses, which are designed to keep professionals updated with the latest clinical practices.

What are the core business areas of Zhongchao Inc?

Its core business areas include healthcare information services, education and clinical training programs, and patient management support, all integrated through a sophisticated digital platform.

How is technology integrated into its business model?

Zhongchao Inc leverages advanced internet technology to provide interactive, digital learning environments and to facilitate efficient communication among hospitals, pharmacies, and other healthcare stakeholders.

What type of patient management services does the company provide?

The company offers digital solutions for patient management, including medication assistance programs and follow-up services that support patients with major diseases, helping to reduce treatment challenges.

How does Zhongchao Inc differentiate itself from traditional healthcare educators?

Unlike traditional providers, Zhongchao Inc integrates clinical training with patient management services and digital healthcare solutions, creating a unique ecosystem that bridges professional education with real-world healthcare challenges.

Who are the primary beneficiaries of Zhongchao Inc's services?

The primary beneficiaries are healthcare professionals seeking continuous education and clinical training, as well as patients who receive support through well-coordinated healthcare management and information services.

How does the company ensure the quality of its educational content?

The educational content is developed in collaboration with medical experts and is based on current clinical research and best practices, ensuring that the information provided is both authoritative and evidence-based.